Afternoon Symposium - ABOG Foundation - Kenneth J. Ryan Ethics Symposium: Incidental Findings in the Era of Whole Genome Sequencing

Date:October 21, 2014

Time:11:15 am - 1:15 pm

Location:Hawaii Convention Center


Paula Amato, M.D. (Chair), Oregon Health & Science University

Laurence B. McCullough, Ph.D., Baylor College of Medicine

John J. Hutton, M.D., University of Cincinnati College of Medicine


Supported by a 2013 endowment from the American Board of Obstetrics and Gynecology

Needs Assessment and Description
Genetic testing is playing an increasingly important role in medically assisted reproduction. Clinicians should be familiar with currently available genetic tests, their limitations, and ethical challenges.

Learning Objectives
At the conclusion of this session, participants should be able to:

  1. Review clinical genetic testing methodologies.
  2. Provide guidelines for the appropriate use of genetic tests.
  3. Discuss ethical issues related to genetic testing.Discuss adverse genetic outcomes of assisted reproductive technology (ART).

ACGME Competency
Patient Care

Both the American College of Obstetricians and Gynecologists (ACOG) and the American College of Medical Genetics (ACMG) recommend that fragile X carrier screening be offered to:
a. Only those with a family history of fragile X
b. Only those with ovarian insufficiency
c. Only those who request it
d. All couples, regardless of race/ethnicity
e. Those with a family history of fragile X, undiagnosed mental retardation/developmental delay/autism, or those with ovarian insufficiency


View Details
Learn More | Join | Renew
Back to Top